Rocket Pharmaceuticals, Inc.
RCKT
$3.39
-$0.15-4.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -12.37% | -1.67% | 9.58% | 4.20% | -12.23% |
| Total Depreciation and Amortization | -13.72% | 26.60% | -1.17% | 0.76% | 5.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.71% | -29.68% | 24.92% | 51.40% | -27.89% |
| Change in Net Operating Assets | 253.15% | -695.12% | -125.35% | -60.96% | 227.87% |
| Cash from Operations | 12.24% | -18.85% | 9.91% | 3.20% | 5.33% |
| Capital Expenditure | 86.26% | -17.80% | 80.54% | 17.72% | 5.16% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 155.16% | -53.54% | -146.66% | 39.88% | 55.26% |
| Cash from Investing | 154.73% | -53.24% | -147.99% | 41.88% | 58.77% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 103,791.48% | -88.50% | 29.22% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | 103,791.48% | -88.50% | 29.22% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 85.08% | -216.11% | 263.20% | 710.33% | 116.14% |